Results 111 to 120 of about 274 (134)

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Nature, 2021
Zijun Wang, Fabian Schmidt, Yiska Weisblum   +2 more
exaly  

mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

Nature Medicine, 2021
Hiam Chemaitelly, Hadi M Yassine, Fatiha M Benslimane   +2 more
exaly  

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Science, 2022
Peter B Gilbert, David C Montefiori, Adrian B Mcdermott   +2 more
exaly  

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

New England Journal of Medicine, 2021
Mark G Thompson, Allison L Naleway, Harmony L Tyner   +2 more
exaly  

Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells

Science, 2021
Jose Mateus, Jennifer M Dan, Zeli Zhang
exaly  

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

Nature, 2021
Alice Cho, Frauke Mücksch, Dennis J Schaefer-Babajew   +2 more
exaly  

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases

Lancet, The, 2022
Richard A Forshee
exaly  

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Science, 2021
Rishi R Goel, Mark M Painter, Sokratis A Apostolidis   +2 more
exaly  

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

Morbidity and Mortality Weekly Report, 2021
Wesley H Self, Manjusha Gaglani, Nicholas M Mohr   +2 more
exaly  

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020

Morbidity and Mortality Weekly Report, 2021
Megan Wallace
exaly